Fujifilm Partners with Chinese Pharmaceutical Company Carelink in Deploying Anti-influenza Drug Avigan® Tablets in China TOKYO, October 22, 2020 — FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada) has announced that the company has partnered with Chinese pharmaceutical company Carelink Pharmaceutical Co., Ltd. (hereinafter “Carelink”) in deploying anti-influenza drug Avigan® Tablets (generic name: favipiravir, “Avigan”) in China. […]
Fujifilm Filed an Application for Partial Changes to the Manufacturing and Marketing Approval Matters of Anti-Influenza Drug Avigan® Tablet in Japan to Include Additional Indication for COVID-19 TOKYO, October 16, 2020 — FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada; hereinafter “FUJIFILM Toyama Chemical”) has announced that the company filed an Application for Partial Changes to […]
Eli Lilly and Company of the United States is entrusted with the manufacture of drug substances for antibody drugs for the new coronavirus infection, which aims to spread to low- and middle-income countries. FUJIFILM Diosynth Biotechnologies (FDB), a subsidiary of FUJIFILM Corporation (President: Kenji Sukeno), a contract development and manufacturing company (CDMO) * 2 for biopharmacy * 1 , is Eli Lilly. We are […]
Started Development of Highly Sensitive and Rapid Antigen Test Kit For New Coronavirus Applying silver halide amplification technology for photo development FUJIFILM Corporation (President: Kenji Sukeno) has started the development of a new coronavirus (SARS-CoV-2) antigen test kit. We aim to put the new coronavirus antigen test kit into practical use at an early stage by using […]
Fujifilm Concludes a Manufacturing Contract Agreement with VLP Therapeutics, for a COVID-19 Vaccine Formulation – Process development and manufacture of formulations using lipid nanoparticles Drug Delivery System technology – TOKYO, October 1, 2020 — FUJIFILM Corporation (President: Kenji Sukeno) announces the conclusion of a manufacturing contract agreement with biotechnology company, VLP Therapeutics Japan LLC (Representative […]
Anti-influenza drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 patients TOKYO, September 23, 2020 — FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada; hereinafter “FUJIFILM Toyama Chemical”) has announced today that primary endpoint has been met in phase III clinical trial of “Avigan Tablet” (generic name: favipiravir, “Avigan”) conducted […]
